Torrent Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 6/6
Torrent Pharmaceuticals 의 총 주주 지분은 ₹75.0B 이고 총 부채는 ₹30.5B, 이는 부채 대 자기자본 비율을 40.6% 로 가져옵니다. 총자산과 총부채는 각각 ₹150.9B 및 ₹75.8B 입니다. Torrent Pharmaceuticals 의 EBIT는 ₹28.0B 이며 이자보상배율은 9.8 입니다. ₹12.4B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
40.6%
부채 비율
₹30.48b
부채
| 이자 보상 비율 | 9.8x |
| 현금 | ₹12.35b |
| 주식 | ₹75.04b |
| 총 부채 | ₹75.84b |
| 총 자산 | ₹150.88b |
최근 재무 상태 업데이트
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23재무 상태 분석
단기부채: TORNTPHARM 의 단기 자산 ( ₹58.8B )이 단기 부채( ₹48.5B ).
장기 부채: TORNTPHARM 의 단기 자산( ₹58.8B )이 장기 부채( ₹27.4B ).
부채 대 자본 내역 및 분석
부채 수준: TORNTPHARM 의 순부채 대 자기자본 비율( 24.2% )은 satisfactory로 간주됩니다.
부채 감소: TORNTPHARM 의 부채 대 자기자본 비율은 지난 5년간 118.6% 에서 40.6% 로 감소했습니다.
부채 범위: TORNTPHARM 의 부채는 영업 현금 흐름 ( 111.8% )에 의해 잘 충당되었습니다.
이자 보장: TORNTPHARM 의 부채에 대한 이자 지급은 EBIT( 9.8 x 적용 범위)로 잘 충당됩니다.